Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ascendis Pharma A (ASND) Assets Average: 2013-2025

Historic Assets Average for Ascendis Pharma A (ASND) over the last 11 years, with Sep 2025 value amounting to $1.3 billion.

  • Ascendis Pharma A's Assets Average rose 27.93% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 27.93%. This contributed to the annual value of $1.1 billion for FY2024, which is 8.24% up from last year.
  • According to the latest figures from Q3 2025, Ascendis Pharma A's Assets Average is $1.3 billion, which was up 9.94% from $1.2 billion recorded in Q2 2025.
  • Ascendis Pharma A's 5-year Assets Average high stood at $1.5 billion for Q1 2021, and its period low was $844.2 million during Q2 2024.
  • Over the past 3 years, Ascendis Pharma A's median Assets Average value was $1.0 billion (recorded in 2024), while the average stood at $1.0 billion.
  • As far as peak fluctuations go, Ascendis Pharma A's Assets Average spiked by 350.23% in 2021, and later slumped by 34.69% in 2023.
  • Ascendis Pharma A's Assets Average (Quarterly) stood at $1.3 billion in 2021, then decreased by 10.02% to $1.2 billion in 2022, then decreased by 23.25% to $919.4 million in 2023, then surged by 33.87% to $1.2 billion in 2024, then climbed by 27.93% to $1.3 billion in 2025.
  • Its last three reported values are $1.3 billion in Q3 2025, $1.2 billion for Q2 2025, and $1.2 billion during Q1 2025.